Korean J Ophthalmol.  2012 Aug;26(4):277-284. 10.3341/kjo.2012.26.4.277.

Long-term Results of Lens-sparing Vitrectomy for Progressive Posterior-type Stage 4A Retinopathy of Prematurity

Affiliations
  • 1Department of Ophthalmology, Inje University Sanggye Paik Hospital, Seoul, Korea.
  • 2Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea. ysyu@snu.ac.kr
  • 3Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Korea.

Abstract

PURPOSE
To assess the long-term anatomic and visual outcomes and associated complications of lens-sparing vitrectomy (LSV) in infants with progressive posterior-type tractional retinal detachment (TRD) associated with stage 4A retinopathy of prematurity (ROP).
METHODS
In a retrospective case series, the medical records of consecutive patients who presented with progressive posterior-type stage 4A ROP and underwent LSV between 1999 and 2007 were reviewed. Retinal attachment status, visual acuity, and development of postoperative complications were assessed.
RESULTS
Eleven eyes of 9 patients were included. The mean follow-up period was 4.6 years. In 8 eyes (73%), plus disease was present at the time of LSV. In 3 eyes (27%), 2 (66%) without plus disease and 1 (13%) with plus disease, the retina remained reattached in the end, while 8 eyes (73%) had TRD on final examination. Two eyes with reattached retinas showed favorable visual acuity. In those eyes with detached retinas, 5 (68%) showed no light perception. When surgery for ROP was unsuccessful, development of cataract, corneal opacity, or glaucoma was common.
CONCLUSIONS
The long-term anatomic success rate of LSV for progressive posterior-type stage 4A ROP was low, especially in the presence of plus disease at the time of LSV. Anatomical reattachment is very important for preventing complications and gaining better visual outcomes.

Keyword

Lens-sparing vitrectomy; Plus disease; Posterior; Retinopathy of prematurity; Stage 4A

MeSH Terms

Disease Progression
Female
Humans
Infant
Infant, Newborn
Male
Postoperative Complications/epidemiology
Retinal Detachment/epidemiology
Retinopathy of Prematurity/*surgery
Retrospective Studies
Treatment Outcome
Visual Acuity
Vitrectomy/*methods

Figure

  • Fig. 1 Fundus photographs of case 10 before and after lens-sparing vitrectomy. (A,B) Fundus photographs obtained before surgery show extraretinal fibrovascular proliferation and tractional retinal detachment of the nasal and temporal retina at posterior zone II with vitreous hemorrhage. (C) Fundus photographs obtained at 40 months after surgery show recurrence of tractional retinal detachment with fibrovascular proliferation. This case underwent additional vitrectomy and lensectomy, but lensectomy resulted in failure.

  • Fig. 2 Fundus photographs of case 11 before and after lens-sparing vitrectomy. (A,B) Fundus photographs obtained before surgery show extraretinal fibrovascular proliferation at nasal and temporal retina and tractional retinal detachment of nasal retina at zone I. (C) Fundus photographs obtained at 7 months after surgery show total tractional retinal detachment. This case underwent lensectomy due to secondary pupillary-block glaucoma.


Cited by  1 articles

Refractive Outcomes of 4-Year-old Children after Intravitreal Anti-vascular Endothelial Growth Factor versus Laser Photocoagulation for Retinopathy of Prematurity
Hyun Goo Kang, Tae Young Kim, Jinu Han, Sueng-Han Han
Korean J Ophthalmol. 2019;33(3):272-278.    doi: 10.3341/kjo.2019.0011.


Reference

1. Capone A Jr, Trese MT. Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments. Ophthalmology. 2001; 108:2068–2070. PMID: 11713081.
Article
2. Moshfeghi AA, Banach MJ, Salam GA, Ferrone PJ. Lens-sparing vitrectomy for progressive tractional retinal detachments associated with stage 4A retinopathy of prematurity. Arch Ophthalmol. 2004; 122:1816–1818. PMID: 15596585.
3. Hubbard GB 3rd, Cherwick DH, Burian G. Lens-sparing vitrectomy for stage 4 retinopathy of prematurity. Ophthalmology. 2004; 111:2274–2277. PMID: 15582086.
Article
4. Lakhanpal RR, Sun RL, Albini TA, Holz ER. Anatomic success rate after 3-port lens-sparing vitrectomy in stage 4A or 4B retinopathy of prematurity. Ophthalmology. 2005; 112:1569–1573. PMID: 16005974.
Article
5. Yu YS, Kim SJ, Kim SY, et al. Lens-sparing vitrectomy for stage 4 and stage 5 retinopathy of prematurity. Korean J Ophthalmol. 2006; 20:113–117. PMID: 16892648.
Article
6. Micelli Ferrari T, Furino C, Lorusso VV, et al. Three-port lens-sparing vitrectomy for aggressive posterior retinopathy of prematurity: early surgery before tractional retinal detachment appearance. Eur J Ophthalmol. 2007; 17:785–789. PMID: 17932856.
7. El Rayes EN, Vinekar A, Capone A Jr. Three-year anatomic and visual outcomes after vitrectomy for stage 4B retinopathy of prematurity. Retina. 2008; 28:568–572. PMID: 18398359.
Article
8. Bhende P, Gopal L, Sharma T, et al. Functional and anatomical outcomes after primary lens-sparing pars plana vitrectomy for Stage 4 retinopathy of prematurity. Indian J Ophthalmol. 2009; 57:267–271. PMID: 19574693.
Article
9. Moshfeghi AA, Awner S, Salam GA, Ferrone PJ. Excellent visual outcome and reversal of dragging after lens sparing vitrectomy for progressive tractional stage 4a retinopathy of prematurity retinal detachment. Retina. 2004; 24:615–616. PMID: 15300086.
Article
10. Prenner JL, Capone A Jr, Trese MT. Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity. Ophthalmology. 2004; 111:2271–2273. PMID: 15582085.
Article
11. Lakhanpal RR, Sun RL, Albini TA, et al. Visual outcomes after 3-port lens-sparing vitrectomy in stage 4 retinopathy of prematurity. Arch Ophthalmol. 2006; 124:675–679. PMID: 16682589.
Article
12. Lakhanpal RR, Davis GH, Sun RL, et al. Lens clarity after 3-port lens-sparing vitrectomy in stage 4A and 4B retinal detachments secondary to retinopathy of prematurity. Arch Ophthalmol. 2006; 124:20–23. PMID: 16401780.
Article
13. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005; 123:991–999. PMID: 16009843.
14. Azuma N, Ishikawa K, Hama Y, et al. Early vitreous surgery for aggressive posterior retinopathy of prematurity. Am J Ophthalmol. 2006; 142:636–643. PMID: 17011857.
Article
15. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. II. The classification of retinal detachment. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity. Arch Ophthalmol. 1987; 105:906–912. PMID: 3606449.
16. Maguire AM, Trese MT. Lens-sparing vitreoretinal surgery in infants. Arch Ophthalmol. 1992; 110:284–286. PMID: 1736880.
Article
17. Hartnett ME. Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity. Retina. 2003; 23:322–329. PMID: 12824831.
Article
18. Kondo H, Arita N, Osato M, et al. Late recurrence of retinal detachment following successful vitreous surgery for stages 4B and 5 retinopathy of prematurity. Am J Ophthalmol. 2009; 147:661–666.e1. PMID: 19152870.
Article
19. Yokoi T, Hiraoka M, Miyamoto M, et al. Vascular abnormalities in aggressive posterior retinopathy of prematurity detected by fluorescein angiography. Ophthalmology. 2009; 116:1377–1382. PMID: 19481811.
Article
20. Yokoi T, Yokoi T, Kobayashi Y, et al. Risk factors for recurrent fibrovascular proliferation in aggressive posterior retinopathy of prematurity after early vitreous surgery. Am J Ophthalmol. 2010; 150:10–15.e1. PMID: 20609704.
Article
21. Kusaka S, Shima C, Wada K, et al. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol. 2008; 92:1450–1455. PMID: 18621796.
Article
22. Law JC, Recchia FM, Morrison DG, et al. Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity. J AAPOS. 2010; 14:6–10. PMID: 20227614.
Full Text Links
  • KJO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr